Shea Wihlborg researches multiomics at ARK Invest, studying technologies that could change medicine. She previously covered biotechnology equities at Barclays and advised biotechnology companies on investor communications at LifeSci Advisors.

Unclaimed profile

Shea Wihlborg researches multiomics at ARK Invest, studying technologies that could change medicine. She previously covered biotechnology equities at Barclays and advised biotechnology companies on investor communications at LifeSci Advisors.

Career

Research Analyst, Multiomics at ARK Invest until Present

Shea's Collections

Shea's Lists

In these lists

Cosigns Given